Large-Scale Data-Driven Intelligence Frameworks for Predictive Healthcare Analytics, Early Clinical Intervention, and Sustainable Chronic Disease Management in the United States
DOI:
https://doi.org/10.63125/7v9wcf33Keywords:
Predictive Healthcare Analytics, Data-Driven Intelligence Frameworks, Clinical Decision Support, Early Intervention, Chronic Disease ManagementAbstract
This study addresses the problem that many U.S. healthcare organizations can build predictive models but struggle to scale them into reliable, workflow-embedded, and governable intelligence frameworks that consistently enable early clinical intervention and sustainable chronic disease management. The purpose was to quantify, across published enterprise and cloud enabled implementations, which end-to-end design elements (data integration, predictive evaluation discipline, workflow actionability, and governance) are most strongly associated with measurable operational and patient-impact signals. Using a quantitative cross-sectional, case-based synthesis, each included study was treated as a “case” drawn from enterprise health systems, multi-site networks, payer programs, and cloud or app-platform deployments (for example, standards-based interoperable apps), and coded for key variables: data readiness (EHR, claims, device and patient-generated integration), model and information quality (validation and utility reporting), workflow fit (CDS embedding and routing), governance (monitoring, privacy, equity), and sustainability indicators (utilization, mortality, continuity). The analysis plan combined descriptive statistics (frequencies and proportions), cross-case comparison matrices, and a light numeric evidence-rating procedure (Likert 1–5) to summarize strength and consistency of effects. Headline findings show that workflow-embedded decision support most consistently improved care processes: across 148 trials, 86% assessed process outcomes and significant improvements were reported for preventive services (OR = 1.42, 95% CI 1.27–1.58), ordering clinical studies (OR = 1.72, 95% CI 1.47–2.00), and prescribing therapies (OR = 1.57, 95% CI 1.35–1.82), while only 20% assessed clinical outcomes and 15% assessed costs. For chronic disease sustainability, remote monitoring and structured support in heart failure reduced admissions by 21% (95% CI 11%–31%) and all-cause mortality by 20% (95% CI 8%–31%), and diabetes self-management apps improved HbA1c by a median 0.4%. Implications are that organizations should treat predictive analytics as a governed data-to-action capability, prioritizing interoperable pipelines, decision-utility evaluation, alert-fatigue controls, subgroup equity checks, and lifecycle monitoring to achieve scalable and durable impact.
